Platelet aggregates detected by a conventional hematology analyzer method is a risk factor for stroke or a predictive factor in patients with chronic-stage cerebral infarction

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Mie ShimizuYukito Shinohara

Abstract

Assessment of platelet activation and/or function is important for primary and secondary prevention of vascular events. To test the hypothesis that determination of platelet aggregation in patients with chronic-stage cerebral infarction (CI) provides a simple measure of risk for ischemic stroke, we used a conventional hematology analyzer to detect aggregates and to assess the efficacy of antiplatelet agents in preventing spontaneous aggregate formation. Platelet aggregates were measured in citrated blood from 142 magnetic resonance imaging confirmed CI patients and 97 controls without CI (nonstroke). Aggregates were detected in 1 of 36 (2.8%) nonstroke subjects without risk factors, but in 24 of 52 (46.2%) nonstroke subjects with risk factors (odds ratio [OR], 3.32; 95% confidence interval [CI], 1.10-10.00), in 21 of 35 (60.0%) nonstroke subjects with a predictive factor (carotid artery intima-media thickness [IMT] >1.1 mm) (OR, 9.13; 95% CI, 2.70-30.48), and in 31 of 63 (49.2%) CI patients who had not received antiplatelet therapy (OR, 2.16; 95% CI, 1.12-4.17). After adjusting for other risk factors, the appearance of platelet aggregates was correlated only with IMT ≥1.1 mm. The rate of appearance of platelet aggregates was 0....Continue Reading

References

Nov 1, 1990·Stroke; a Journal of Cerebral Circulation·N HandaT Kamada
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Aug 13, 2003·International Journal of Epidemiology·X ZhangUNKNOWN Asia Pacific Cohort Studies Collaboration
Aug 17, 2004·American Heart Journal·Deepak L BhattUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee
Aug 25, 2004·Neurology·Hisayuki HirabayashiYukito Shinohara
Mar 12, 2005·Journal of the Neurological Sciences·Laszlo K SztrihaLaszlo Vecsei
Oct 26, 2005·Circulation·Jane E Freedman
Dec 20, 2005·Journal of Thrombosis and Haemostasis : JTH·F M PulcinelliF Violi
Apr 26, 2006·Journal of Thrombosis and Haemostasis : JTH·M ShimizuI Kuwahira
Jul 21, 2006·Pathophysiology of Haemostasis and Thrombosis·Alan D Michelson
Aug 5, 2006·Stroke; a Journal of Cerebral Circulation·Patrik HtunMeinrad Gawaz
Jun 6, 2007·Thrombosis and Haemostasis·Suzanne Fateh-MoghadamMeinrad Gawaz
Jan 12, 2008·The American Journal of Medicine·Jeffrey S BergerRichard C Becker
Jan 18, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·G TargherG Arcaro
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan

❮ Previous
Next ❯

Citations

Feb 17, 2017·Scientific Reports·Tomohiro MizunoMasaki Imai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.